Thank you for the work on this.
I have a tangentially related question, hoping that someone knowledgeable can answer. What are the main bottlenecks to scaling testing, in particular in the following stages:
- the supply of virus-specific reagents (primers, perhaps virus-specific reporting probes - are these necessary, or can just generic reporters be used?)
- the supply of other reagents (in case of PCR, polymerase, nucleotide material, buffer)
- the supply of disposable testing equipment. I know that swabs are in short supply for some reason, anything else?
- safety in handling both the samples and the amplified product (can you basically flush the processed sample down the toilet, or do you need to handle it with extreme precautions)
I have a tangentially related question, hoping that someone knowledgeable can answer. What are the main bottlenecks to scaling testing, in particular in the following stages:
- the supply of virus-specific reagents (primers, perhaps virus-specific reporting probes - are these necessary, or can just generic reporters be used?)
- the supply of other reagents (in case of PCR, polymerase, nucleotide material, buffer)
- the supply of disposable testing equipment. I know that swabs are in short supply for some reason, anything else?
- safety in handling both the samples and the amplified product (can you basically flush the processed sample down the toilet, or do you need to handle it with extreme precautions)